{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:58:00Z","timestamp":1791356280984,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.cancergen.2011.12.005","type":"journal-article","created":{"date-parts":[[2012,3,31]],"date-time":"2012-03-31T01:00:56Z","timestamp":1333155656000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations"],"prefix":"10.1016","volume":"205","author":[{"given":"Iwona K.","family":"Rzepecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Szafron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Stys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Bujko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Plisiecka-Halasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslaw","family":"Madry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Osuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Markowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Bidzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Kupryjanczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2011.12.005_bib1","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1200\/JCO.2007.11.3902","article-title":"Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway","volume":"26","author":"Weberpals","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2011.12.005_bib2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.humpath.2005.06.006","article-title":"Hereditary ovarian cancer","volume":"36","author":"Prat","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cancergen.2011.12.005_bib3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molonc.2009.02.001","article-title":"The contribution of BRCA1 and BRCA2 to ovarian cancer","volume":"3","author":"Ramus","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.cancergen.2011.12.005_bib4","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1158\/1078-0432.CCR-08-1291","article-title":"Genome-wide loss of heterozygosity and uniparental disomy in BRCA1\/2-associated ovarian carcinomas","volume":"14","author":"Walsh","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2011.12.005_bib5","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1158\/1078-0432.CCR-1029-3","article-title":"Pathology of ovarian cancers in BRCA1 and BRCA2 carriers","volume":"10","author":"Lakhani","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2011.12.005_bib6","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0046-8177(00)80014-3","article-title":"Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations","volume":"31","author":"Werness","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cancergen.2011.12.005_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/path.1507","article-title":"Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene","volume":"202","author":"Wang","year":"2004","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.cancergen.2011.12.005_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/6029","article-title":"Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas","volume":"21","author":"Wilson","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2011.12.005_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/gyno.1999.5664","article-title":"Reduction of BRCA1 expression in sporadic ovarian cancer","volume":"76","author":"Zheng","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"suppl 1","key":"10.1016\/j.cancergen.2011.12.005_bib10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/ijgc-00009577-200602001-00026","article-title":"BRCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study","volume":"16","author":"Thrall","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.cancergen.2011.12.005_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF03195697","article-title":"Loss of heterozygosity at BRCA1\/2 loci in hereditary and sporadic ovarian cancers","volume":"50","author":"Brozek","year":"2009","journal-title":"J\u00a0Appl Genet"},{"key":"10.1016\/j.cancergen.2011.12.005_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yexcr.2006.09.026","article-title":"Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes","volume":"313","author":"Clark-Knowles","year":"2007","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cancergen.2011.12.005_bib13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ygyno.2004.08.035","article-title":"No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers","volume":"95","author":"Aghmesheh","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cancergen.2011.12.005_bib14","first-page":"831","article-title":"The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer","volume":"7","author":"Buller","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2011.12.005_bib15","first-page":"3193","article-title":"Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers","volume":"58","author":"Rhei","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2011.12.005_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/1097-0215(20001015)88:2<319::AID-IJC27>3.0.CO;2-X","article-title":"Loss of heterozygosity (LOH) at p53 is correlated with LOH at BRCA1 and BRCA2 in various human malignant tumors","volume":"88","author":"Tong","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2011.12.005_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1098-2264(199905)25:1<65::AID-GCC10>3.0.CO;2-F","article-title":"Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancer","volume":"25","author":"Villeneuve","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2011.12.005_bib18","series-title":"Pathology and genetics of tumours of the breast and female genital organs","author":"Tavassoli","year":"2003"},{"key":"10.1016\/j.cancergen.2011.12.005_bib19","first-page":"795","article-title":"Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer","volume":"121","author":"Barber","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cancergen.2011.12.005_bib20","first-page":"125","article-title":"Announcement, FIGO stages 1988, revisions","volume":"35","author":"Creasman","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cancergen.2011.12.005_bib21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1469-1809.2006.00257.x","article-title":"Geographical variations in TP53 mutational spectrum in ovarian carcinomas","volume":"70","author":"Dansonka-Mieszkowska","year":"2006","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.cancergen.2011.12.005_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4161\/cbt.8.1.7209","article-title":"PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients","volume":"8","author":"Kolasa","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.cancergen.2011.12.005_bib23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ygyno.2006.05.007","article-title":"PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations","volume":"103","author":"Kolasa","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cancergen.2011.12.005_bib24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","article-title":"Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors","volume":"92","author":"Esteller","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2011.12.005_bib25","first-page":"3410","article-title":"Epigenetic patterns in the progression of esophageal adenocarcinoma","volume":"61","author":"Eads","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2011.12.005_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-8-17","article-title":"Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities","volume":"8","author":"Press","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cancergen.2011.12.005_bib27","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/cncr.21276","article-title":"Prognostic impact of BRCA1 pathogenic and BRCA1\/BRCA2 unclassified variant mutations in patients with ovarian carcinoma","volume":"104","author":"Majdak","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2011.12.005_bib28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ijc.11338","article-title":"Hereditary ovarian cancer in Poland","volume":"106","author":"Menkiszak","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2011.12.005_bib29","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1086\/302922","article-title":"Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer","volume":"66","author":"Gorski","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2011.12.005_bib30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1399-0004.2003.00178.x","article-title":"Frequency of three BRCA1 gene founder mutations in breast\/ovarian cancer families from the Pomerania-Kujawy region of Poland","volume":"64","author":"Janiszewska","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergen.2011.12.005_bib31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc2946","article-title":"The genesis and evolution of high-grade serous ovarian cancer","volume":"10","author":"Bowtell","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cancergen.2011.12.005_bib32","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergen.2011.12.005_bib33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B","article-title":"Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers","volume":"87","author":"Russell","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2011.12.005_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jnci\/94.1.61","article-title":"Frequency of BRCA1 dysfunction in ovarian cancer","volume":"94","author":"Geisler","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2011.12.005_bib35","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1038\/sj.onc.1210451","article-title":"Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation","volume":"26","author":"Jeng","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2011.12.005_bib36","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jnci\/92.13.1088","article-title":"Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53","volume":"92","author":"Werness","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2011.12.005_bib37","first-page":"5329","article-title":"BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study","volume":"60","author":"Baldwin","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2011.12.005_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5","article-title":"Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours","volume":"25","author":"Ramus","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2011.12.005_bib39","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/jcp.52.5.372","article-title":"Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations","volume":"52","author":"Zweemer","year":"1999","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cancergen.2011.12.005_bib40","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/jnci\/94.13.990","article-title":"Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers","volume":"94","author":"Jazaeri","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2011.12.005_bib41","first-page":"417","article-title":"BRCA1\/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases","volume":"63","author":"Ramus","year":"2003","journal-title":"Cancer Res"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212000026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212000026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:37:40Z","timestamp":1761896260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776212000026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S2210776212000026"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2011.12.005","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2011.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}